Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market

NEXT STORY
BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing
PREV STORY
Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OPKO’S GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing

MIAMI, June 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq:OPK) announced today that ...

author_avatar
NASDAQ Market News

Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec

author_avatar
NASDAQ Market News

Nymox’s Fexapotide Featured in Broadcast of Grand Rounds in Urology

HASBROUCK HEIGHTS, N.J., May 11, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is ...

author_avatar
NASDAQ Market News